Navigation Links
Researchers gain new insight on wonder of cell division
Date:12/4/2008

Biologists have discovered a mechanism that is critical to cytokinesis -- nature's completion of mitosis, where a cell divides into two identical daughter cells.

The researchers have opened a new window on the assembly and activity of a ring of actin and myosin filaments that contract to pinch a cell at just the right time. They focused on key proteins whose roles drive signaling mechanisms that promote the production of both linear and branching microfilaments along the inside surface membrane of a dividing cell. By down-regulating the production of branched microfilaments at the right time, the membrane may be more malleable and better able to pinch inward and complete cytokinesis.

The findings-- detailed in the Dec. 5 issue of the journal Science -- come from basic research using Caenorhabditis elegans (roundworm) embryos. The discovery provides more basic insight than immediate biomedical application, but the implications could lead to a fine-tuning of anti-cancer drug therapies or to isolating new targets for drugs to stop cancerous cell division, said Bruce Bowerman, professor of biology in the University of Oregon's Institute for Molecular Biology.

Bowerman and Karen Oegema of the Ludwig Institute for Cancer Research at the University of California, San Diego, were principal investigators of a seven-member team funded by the National Institutes of Health.

Scientists have theorized that the modulation of microfilament structure plays a role in healthy cell division. However, finding that such shape-shifting down-regulation specifically targets branched microfilaments assembly came as a surprise, Bowerman said.

C. elegans is used in many genetics research laboratories to discover basic requirements for the 20,000 genes that compose its genome; most of the genes are conserved in humans and carry out similar processes. Using these nematodes, Bowerman said, is allowing researchers to "find players inside
'/>"/>

Contact: Jim Barlow
jebarlow@uoregon.edu
541-346-3481
University of Oregon
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective
2. LA BioMed researchers among Southern California Super Doctors
3. Researchers discover new enzyme in cancer growth
4. Researchers identify cell group key to Lyme disease arthritis
5. Interferon needed for cells to remember how to defeat a virus, UT Southwestern researchers report
6. Children Tell Researchers: Well Get Fit if Its Fun
7. Researchers identify how binge drinking may drive heart disease
8. UCSD researchers identify potential new drug target for chronic leukemia
9. USC researchers identify novel approach for suppressing prostate cancer development
10. Researchers identify new leprosy bacterium
11. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers gain new insight on wonder of cell division
Researchers gain new insight on wonder of cell division
(Date:11/28/2009)...eved to affect circadian rhythm, , ,... suggests that an internal body clock that goes on... bipolar disorder in children. , The finding r...of 152 children with bipolar disorder, which can m...40 children without the disorder. They linked vari...
(Date:11/27/2009)...ch firm Replikins Ltd. today issued its latest bio... It shows that the lethality of the virus has drop...us,s current outbreak in the spring of 2009 to res...1). The H1N1 infectivity count, however, remains i...) November 27, 2009 -- Biotech firm Replikins Ltd....
(Date:11/27/2009)..., France, Nov. 27 Team Garmin-Slip...am dedicated to ethical sporting and developing th...today that it will become Team Garmin-Transitions ...sponsor of the team. Transitions Optical is the wo...fering the most advanced photochromic technology i...
(Date:11/27/2009)...ented medical, economic burdens, study predicts ,...e number of people with diabetes in the United Sta...a new study predicts. , That would bring the to...disease, up from 23.7 million today. , , At the ...es will triple, the study also warns, rising from ...
(Date:11/27/2009)...alist manufacturers who use medical load cells at ... dollars by bringing in technology partner Flintec...f pro-active medical manufacturers are calling in ...their projects, ensuring that progress will not be...tially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...ent Systems,Inc. (HMS) today announced that it has.... d/b/a/ Permedion, an independent health care qua...Westerville, Ohio. With this,acquisition, HMS augm...rmedion utilizes advanced data mining algorithms b...
...f the Population of Singapore to Use Eclipsys Sol...tiple Facilities -, ... (Nasdaq: ECLP ), The Outcomes Company(R), today ...record,platform. SingHealth, which serves an estim...
...Technology Fast 50 List for Maryland for a fourth...g technology compani...ices, Inc.,has been named for a fourth straight ye...ife sciences companies,in Maryland, by Deloitte & ...
...udy finds that white women more frequently take mo...sed to treat breast cancer than African-American ...ad to the lymph nodes were less likely to have adj...y therapy. Studies suggest adjuvant therapy may in...
...Women and Men From 46 States and 7 ...than 3,900 participants in this,weekend,s fifth an...10.2,million to advance access to care and finding...nitial grants, with millions,more slated to be awa...
...ll, study finds , SUNDAY, Oct. 7 (HealthDay News) ...r and fall have a better chance of survival than t...dy of Norwegian men suggests. , "Summer and autumn...est that this possibility should be studied furthe...
Other Medicine News:Health News:HMS Acquires Permedion to Expand Clinical Review Capabilities 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 3Health News:CBaySystems Selected to Receive Deloitte's 2007 Maryland Technology Fast 50 Award 2Health News:CBaySystems Selected to Receive Deloitte's 2007 Maryland Technology Fast 50 Award 3Health News:Whites take supplemental breast cancer therapy more often than blacks 2Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 2Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 3Health News:Prostate Cancer Survival Varies by Season 2
(Date:11/25/2009)..., , WESTON, Fla., Nov. 25 /PRNewswire...(Pink Sheets: ASFX) ("the Company") is pleased to ...g and production management office in Shanghai, Ch...abroad, providing an essential gateway for the dev...th and safety products for children and adults to ...
(Date:11/25/2009)..., , PRINCETON, N.J., Nov. 25 /PRNewswire-F...clinical stage pharmaceutical company committed to... drugs to treat viral infections, reported financi... 2009. At September 30, 2009 Pharmasset held $58.4...investments. ,, Pipeline Update and 2009 High...
(Date:11/25/2009)..., , EXTON, Pa., Nov. 25 Bi...s LaunchTrends(TM) : Stelara report, the fi...oject tracking the launch of Centocor Ortho-Biotec... six months of availability. Each wave of the rep...ue Dermatologists and qualitative information from...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2NeurogesX Expands Commercial Operations Leadership Team 6009 1NeurogesX Expands Commercial Operations Leadership Team 6009 2NeurogesX Expands Commercial Operations Leadership Team 6009 3NeurogesX Expands Commercial Operations Leadership Team 6009 4NeurogesX Expands Commercial Operations Leadership Team 6009 5NeurogesX Expands Commercial Operations Leadership Team 6009 6Reminder Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 6007 1Reminder Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 6007 2Babies language learning starts from the womb 60760 1Babies language learning starts from the womb 60760 2
... 10 YMed, Inc. announced today that it,has succes...prietary,VascuTraK(TM) II PTA Dilatation Catheter....compatible, single operator rapid exchange system....d indicated for vascular,intervention of a wide ra...,of obstructive lesions of native or synthetic art...
...., Dec. 10 The US Food and,Drug Administration (F...,open, long-term, clinical studies in patients wit...ng anti-reflux surgery with either omeprazole,(SOP... AstraZeneca (NYSE: AZN ) agrees with the FDA con...at long-term use of these drugs is not likely,to b...
Other Medicine Technology:YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 3FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 4
...d has been developing diverse medical products for... have earned an outstanding reputation for innovat...lds internationally recognized brands include the ...o® medical sundry products, Bristoline® mi...
...llest nebulizer utilizing Vibrating Mesh Technolog...patients suffering from Asthma, COPD or other resp...product size and handy carrying case that is easil...elivery comparable to table-top compressor nebuliz...
...reg; Air Entrainment Nebulizers deliver particulat...onic secretion patients. For your convenience, The...ting supply of sterile water., ,The P30000N, for ... with a total flow range of 68-24 lpm. For your hi...
...y of medication as well as humidification, try Flo... closed dilution, high volume, continuous medicati...alation therapy to patients. Its 200 ml reservoir ...ulized medication delivery at 25 ml/hr. Particles ...
Medicine Products: